Comparative Effects of Two Neutralizing Anti-Respiratory Syncytial Virus (RSV) Monoclonal Antibodies in the RSV Murine Model: Time versus Potency - Mejías, Asunción; Chávez-Bueno, Susana; Ríos, Ana María; Aten, Mónica Fonseca; Raynor, Brett; Peromingo, Estrella; Soni, Perla; Olsen, Kurt D.; Kiener, Peter A.; Gómez, Ana María; Jafri, Hasan S.; Ramilo, Octavio (Antimicrobial Agents and Chemotherapy, 2005)
Keywords: Airway Obstruction - prevention & control; Animals; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antibodies, Monoclonal; Antibodies, Monoclonal - therapeutic use; Antibodies, Monoclonal, Humanized; Antiviral Agents; Antiviral Agents - therapeutic use; Biological and medical sciences; Bronchial Hyperreactivity - prevention & control; Disease Models, Animal; Experimental Therapeutics; Female; Lung - pathology; Medical sciences; Mice; Mice, Inbred BALB C; Palivizumab; Pharmacology. Drug treatments; Polymerase Chain Reaction; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Infections - complications; Respiratory Syncytial Virus Infections - drug therapy; Respiratory Syncytial Virus Infections - pathology; Virus Replication - drug effects; Human respiratory syncytial virus; Animal model; Pneumovirinae; Rodentia; Monoclonal antibody; Paramyxoviridae; Virus; Respiratory tract; Mononegavirales; Vertebrata; Mammalia; Mouse; Pneumovirus; Comparative study